Clinical Trial Update: Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update describes reward-related dopamine signaling in the brains of healthy individuals and people with major depressive disorder. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Medical University of Vienna | Conditions: Major Depressive Disorder (MDD) | Phase 4 | Status: RECRUITING